Total shoulder arthroplasty (TSA) is becoming increasingly more common as a treatment for disabling pain or impaired shoulder function. Dr. Jonelle Petscavage, a Medical Metrics’ (MMI) consultant, recently published a two-part review in the American Journal of Roentgenology on the current state-of-the-art in shoulder arthroplasty. Covering topics such as epidemiology, history, preoperative imaging, hemiarthroplasty, anatomic and reverse TSA, and non-prosthetic resurfacing, Dr. Petscavage represents the level of expertise that sponsors can expect from collaborating with MMI on their regulated and non-regulated orthopedic studies.
MMI has been able to leverage this expertise in the support of several new stemless shoulder arthroplasties. The stemless humeral component design represents a novel approach to reducing the complication rate found in traditionally-designed TSAs.
About Medical Metrics
Medical Metrics, Inc. (MMI) is an experienced, ISO 9001-certified, independent imaging core lab for multi-center clinical trials. Since 2000, MMI has partnered with clinical trial sponsors to conduct comprehensive imaging evaluations of treatments for musculoskeletal, cardiovascular, and neurological disorders. Trials range from pre-clinical and early-phase clinical studies to pivotal trials and post-approval surveillance. With an ISO-certified quality system, experienced project management team, proprietary data management platform, and luminary group of radiology and cardiology thought-leaders, MMI is uniquely positioned to deliver high-quality imaging core lab services for complex clinical trials.
